Ever since CRISPR was first used to edit human cells in a dish in 2013, scientists have been hopeful about its potential to treat — and hopefully, eliminate — a wide spectrum of genetic diseases.
Millions of people around the world, including around 100,000 in the United States, suffer from sickle cell disease, a brutally painful inherited blood disorder. Most of them are of African descent.
A team of scientists has used the gene-editing technique CRISPR to create genetically modified human embryos in a London lab, and the results of the experiment do not bode well for the prospect of gene-edited babies.
Researchers at Boston Children’s Hospital and the Broad Institute of MIT and Harvard recently took a step toward a future where hereditary deafness could be corrected with a single injection into the ear.
It could be as simple to use as a pregnancy test — but it’s not there yet